Skip to main content
Elsevier - PMC COVID-19 Collection logoLink to Elsevier - PMC COVID-19 Collection
. 2020 May 7. Online ahead of print. doi: 10.1016/j.jaad.2020.04.171

Use of teledermatology by dermatology hospitalists is effective in the diagnosis and management of inpatient disease.

Colleen K Gabel 1,, Emily Nguyen 1,, Ryan Karmouta 2, Kristina Jing Liu 3, Guohai Zhou 4, Allireza Alloo 5, Ryan Arakaki 6, Yevgeniy Balagula 7, Alina G Bridges 8, Edward W Cowen 9, Mark Denis P Davis 8, Alisa Femia 10, Joanna Harp 11, Benjamin Kaffenberger 12, Jesse J Keller 13, Bernice Y Kwong 14, Alina Markova 15, Melissa Mauskar 16, Robert Micheletti 17, Arash Mostaghimi 4, Joseph Pierson 18, Misha Rosenbach 17, Zachary Schwager 19, Lucia Seminario-Vidal 20, Victoria R Sharon 5, Philip I Song 21, Lindsay C Strowd 22, Andrew C Walls 4, Karolyn A Wanat 23, David A Wetter 8, Scott Worswick 24, Carolyn Ziemer 25, Joseph Kvedar 1, Anar Mikailov 26, Daniela Kroshinsky 1,∗∗
PMCID: PMC7204758  PMID: 32389716

Abstract

Background

Patient outcomes are improved when dermatologists provide inpatient consults. Inpatient access to dermatologists is limited, illustrating an opportunity to utilize teledermatology. Little is known about the ability of dermatologists to accurately diagnose and manage inpatients using teledermatology, particularly utilizing non-dermatologist generated clinical data.

Methods

This prospective study assessed the ability of teledermatology to diagnose and manage 41 dermatology consults from a large urban tertiary care center utilizing internal medicine referral documentation and photos. Twenty-seven dermatology hospitalists were surveyed. Interrater agreement was assessed by the kappa statistic.

Results

There was substantial agreement between in-person and teledermatology assessment of the diagnosis with differential diagnosis (median kappa = 0.83), substantial agreement in laboratory work-up decisions (median kappa = 0.67), almost perfect agreement in imaging decisions (median kappa = 1.0), and moderate agreement in biopsy decisions (median kappa = 0.43). There was almost perfect agreement in treatment (median kappa = 1.0), but no agreement in follow-up planning (median kappa = 0.0). There was no association between raw photo quality and the primary plus differential diagnosis or primary diagnosis alone.

Limitations

Selection bias and single-center nature.

Conclusions

Teledermatology may be effective in the inpatient setting, with concordant diagnosis, evaluation, and management decisions.

Keywords: inpatient dermatology, teledermatology, dermatology consultations, store-and-forward, telemedicine, dermatology hospitalists

Footnotes

Funding Sources: None

Conflicts of Interest: None declared.

IRB approval status: Reviewed and approved by Partners IRB: 2018P002762

- Inpatient access to dermatologists is limited, highlighting an opportunity to utilize teledermatology within the inpatient setting.

- Teledermatology in the inpatient setting may be a clinically acceptable option for diagnosis, evaluation, and management. This may represent a novel and effective option for hospitals.


Articles from Journal of the American Academy of Dermatology are provided here courtesy of Elsevier

RESOURCES